Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Jain

Showing results (391-400 of 420) with videos related to

Pageof 42
Sort By:
Journal of the American College of Cardiology|December 21, 2019
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)Raza M Alvi, Matthew J Frigault, Michael G Fradley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2025
Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B cell LymphomaKhushali Jhaveri, Ram Thapa, Dalia Ercan, et al.
Blood Advances|December 5, 2023
Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T ConsortiumMichael D Jain, Miriam T Jacobs, Feng Gao, et al.
Blood|November 6, 2020
Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapyJay Y Spiegel, Saurabh Dahiya, Michael D Jain, et al.
Open Forum Infectious Diseases|October 16, 2024
Outcomes of Haploidentical Stem Cell Transplant Recipients With HHV-6B ReactivationGuy Handley, Amanda Yepes, Eva Eliassen, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2022
Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T ConsortiumMiriam T Jacobs, Michael D Jain, Feng Gao, et al.
Journal of Dental Research|January 13, 2017
GWAS Identifies New Loci for Painful Temporomandibular Disorder: Hispanic Community Health Study/Study of LatinosA E Sanders, D Jain, T Sofer, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 10, 2021
Unhealthy alcohol use independently associated with unfavorable TB treatment outcomes among Indian menS R Cox, A N Gupte, B Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2020
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T ConsortiumLoretta J Nastoupil, Michael D Jain, Lei Feng, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
RHOA Loss of Function Impairs the IFNγ Response and Promotes CD19 Antigen Escape to Drive CAR-T Resistance in Diffuse Large B-cell LymphomaAustin D Newsam, Bachisio Ziccheddu, Venu Venkatarame Gowda Saralamma, et al.
Pageof 42

Showing results (391-400 of 420) with videos related to

Sort By:
Pageof 42
Journal of the American College of Cardiology|December 21, 2019
Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)Raza M Alvi, Matthew J Frigault, Michael G Fradley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2025
Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B cell LymphomaKhushali Jhaveri, Ram Thapa, Dalia Ercan, et al.
Blood Advances|December 5, 2023
Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T ConsortiumMichael D Jain, Miriam T Jacobs, Feng Gao, et al.
Blood|November 6, 2020
Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapyJay Y Spiegel, Saurabh Dahiya, Michael D Jain, et al.
Open Forum Infectious Diseases|October 16, 2024
Outcomes of Haploidentical Stem Cell Transplant Recipients With HHV-6B ReactivationGuy Handley, Amanda Yepes, Eva Eliassen, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2022
Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T ConsortiumMiriam T Jacobs, Michael D Jain, Feng Gao, et al.
Journal of Dental Research|January 13, 2017
GWAS Identifies New Loci for Painful Temporomandibular Disorder: Hispanic Community Health Study/Study of LatinosA E Sanders, D Jain, T Sofer, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 10, 2021
Unhealthy alcohol use independently associated with unfavorable TB treatment outcomes among Indian menS R Cox, A N Gupte, B Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2020
Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T ConsortiumLoretta J Nastoupil, Michael D Jain, Lei Feng, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
RHOA Loss of Function Impairs the IFNγ Response and Promotes CD19 Antigen Escape to Drive CAR-T Resistance in Diffuse Large B-cell LymphomaAustin D Newsam, Bachisio Ziccheddu, Venu Venkatarame Gowda Saralamma, et al.
Pageof 42